(Reuters) – A U.S. health panel may soon make HIV testing as standard a practice as checking cholesterol levels, a move that would fundamentally change how the virus is detected and treated.The U.S. Preventive Services Task force, a government-backed group of clinicians and scientists, is expected t

(Reuters) – A U.S. Food and Drug Administration panel on Thursday recommended two drugs for combating different forms of vision loss that can lead to blindness among a range of adults, including diabetics and the elderly.The FDA advisory committee of outside experts gave its support to Swiss-based R

Health Intervention and Technology Assessment Program (HITAP) led by Dr. Yot Teerawattananon (3rd left), Founding Leader, and HITAP International Unit Staff, welcomed Dr. Seth Franklin Berkley (centre), CEO, Global Alliance for Vaccines and Immunizations (GAVI) on his visit to Thailand. Dr. Yot and

Abstract Background Due to competing health priorities and limited resources, many low-income countries, even those with a high disease burden, are not able to introduce pneumococcal conjugate vaccines. Objective To determine the cost-utility of 10- and 13-valent pneumococcal conjugate vacci

A few years ago, my daughter sprained her ankle at dance camp. What happened next offers a glimpse into some of the problems in our nation’s health care system.For years, we’ve been hearing that the United States spends more on health care than any other country, even as it lags far behind other cou

SUMMARY POINTS •  End stage renal disease (ESRD) is a life-threatening condition that results in most patients requiring a lifetime of high cost renal dialysis •  Governments have grappled with the political, economic, and ethical challenges of providing treatment with their available budgets •

Abstract Background Home dialysis (HoD) remains underutilized, despite evidence showing it provides comparable mortality rates to in-center hemodialysis (ICHD) while offering advantages such as improved quality of life and lower overall costs. This scoping review comprehensively evaluates the

Summary Medicines expenditure consumes a significant proportion of public health expenditure in Thailand, where Universal Health Coverage has been in place since 2002. The National List of Essential Medicines has been successfully used as a pharmaceutical benefits package for all public health plan

Abstract: There is increasing impetus to use pharmaceutical interventions, ie, ranibizumab or bevacizumab, for the treatment of particular macular diseases. This paper describes the evidence and decision-making of the National List of Essential Medicines Committee that recently announced the inclusi